Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25991468.
- Also identified by DOI 10.1093/cid/civ395.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. We present a patient with EVD who received brincidofovir and convalescent plasma. The relative contributions of supportive care, investigational therapies, and patient's immune-response on survival could not be determined. Randomized trials are needed.
Medical subject headings
- Antiviral Agents
- Cytosine
- Hemorrhagic Fever, Ebola
- Immunization, Passive
- Organophosphonates
- Plasma